NEXT Oncology is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 97 clinical trials with 76 currently active.
Therapeutic areas: RAS Mutation, NF1 Mutation, RAF Mutation.
Sponsors: Pasithea Therapeutics Corp., EMD Serono Research & Development Institute, Inc., Astellas Pharma Global Development, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Virginia · View every site in Fairfax
Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 97 clinical trials on record, with 76 currently active. Their work covers RAS Mutation, NF1 Mutation, RAF Mutation.
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.